Bleomycin for Injection, USP
General Information: Bleomycin is typically utilized
in the palliative treatment of lymphoma, squamous cell
carcinoma, testicular carcinoma, and malignant pleural effusion. For indications, dosing and other information, please refer to the manufacture package insert.
|
| |
| Manufacturer |
Product |
Size |
NDC |
PI |
MSDS |
| Hospira |
Bleomycin
|
15 units/
vial |
61703-0323-22 |
PI |
MSDS |
| |
|
30 units/ vial |
61703-0332-30 |
PI |
MSDS |
| |
|
|
|
|
|
| TEVA |
Bleomycin Sulfate |
15 units / vial |
00703-3154-01 |
PI |
MSDS |
| |
|
30 units/ vial |
00703-3155-01 |
PI |
MSDS |
|
| |
| Clinical
Data: For any questions
or for further information
related to Bleomycin for
Injection, clinical
pharmacology, additional
indications and usages,
contraindications, warnings,
precautions, adverse reactions,
dosage, administration and/or
storage of this product, please
contact
BDI Pharma or call 1-800-948-9834. |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |